Citations (166)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Shovana Shrestha, Sherry Dahlke, Jeffrey I. Butler, Rashmi Devkota, Joanna Law, Kathleen F. Hunter, Madeline Toubiana, Maya R. Kalogirou, Melissa Scheuerman & Matthew Pietrosanu. (2024) How older Canadians access medical cannabis and information about it: A descriptive survey. Cogent Gerontology 3:1.
Read now
Read now
Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup. (2024) Exploring medicinal use of low-THC cannabis products - Comparing experienced effects and side-effects between CBD-oil-only users to users of high-THC cannabis products. Drugs: Education, Prevention and Policy 0:0, pages 1-13.
Read now
Read now
Martin Bastien, Salim Mezaache, Cécile Donadille, Victor Martin, Laurent Appel, Maela Lebrun, Laélia Briand Madrid, Tangui Barré & Perrine Roux. (2023) Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey. Journal of Psychoactive Drugs 0:0, pages 1-11.
Read now
Read now
Kathleen J Maddison, Christopher Kosky & Jennifer H Walsh. (2022) Is There a Place for Medicinal Cannabis in Treating Patients with Sleep Disorders? What We Know so Far. Nature and Science of Sleep 14, pages 957-968.
Read now
Read now
Sajed Mangoo, Simon Erridge, Carl Holvey, Ross Coomber, Daniela A Riano Barros, Urmila Bhoskar, Gracia Mwimba, Kavita Praveen, Chris Symeon, Simmi Sachdeva-Mohan, James J Rucker & Mikael H Sodergren. (2022) Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry. Expert Review of Neurotherapeutics 22:11-12, pages 995-1008.
Read now
Read now
Nazeer Hasan, Mohammad Imran, Afsana Sheikh, Suma Saad, Gaurav Chaudhary, Gaurav Kumar Jain, Prashant Kesharwani & Farhan J. Ahmad. (2022) Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials. Journal of Drug Targeting 30:7, pages 709-725.
Read now
Read now
Adrian Szczepaniak & Jakub Fichna. (2020) What role do cannabinoids have in modern medicine as gastrointestinal anti-inflammatory drugs?. Expert Opinion on Pharmacotherapy 21:16, pages 1931-1934.
Read now
Read now
Renata Rizzo & Mariangela Gulisano. (2020) Treatment options for tic disorders. Expert Review of Neurotherapeutics 20:1, pages 55-63.
Read now
Read now
Toni Leigh Mortimer, Tom Mabin & Anna-Mart Engelbrecht. (2019) Cannabinoids: The Lows and the Highs of Chemotherapy-Induced Nausea and Vomiting. Future Oncology 15:9, pages 1035-1049.
Read now
Read now
Ilit Turgeman & Gil Bar-Sela. (2019) Cannabis for cancer – illusion or the tip of an iceberg: a review of the
evidence for the use of Cannabis and synthetic cannabinoids in oncology. Expert Opinion on Investigational Drugs 28:3, pages 285-296.
Read now
Read now
Daniel J. Kruger & Jessica S. Kruger. (2019) Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine. Journal of Psychoactive Drugs 51:1, pages 31-36.
Read now
Read now
Marcel O. Bonn-Miller, Mahmoud A. ElSohly, Mallory J. E. Loflin, Suman Chandra & Ryan Vandrey. (2018) Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches. International Review of Psychiatry 30:3, pages 277-284.
Read now
Read now
Mallory Loflin, Kimberly Babson, Kendall Browne & Marcel Bonn-Miller. (2018) Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. The American Journal of Drug and Alcohol Abuse 44:1, pages 19-23.
Read now
Read now
James M Corroon$suffix/text()$suffix/text(), Laurie K Mischley & Michelle Sexton. (2017) Cannabis as a substitute for prescription drugs – a cross-sectional study. Journal of Pain Research 10, pages 989-998.
Read now
Read now
Namkee G. Choi, Diana M. DiNitto, C. Nathan Marti & Bryan Y. Choi. (2017) Association between Nonmedical Marijuana and Pain Reliever Uses among Individuals Aged 50+. Journal of Psychoactive Drugs 49:4, pages 267-278.
Read now
Read now
Franjo Grotenhermen & Kirsten Müller-Vahl. (2016) Medicinal Uses of Marijuana and Cannabinoids. Critical Reviews in Plant Sciences 35:5-6, pages 378-405.
Read now
Read now
Lawrence A. Osborn, Kirstin J. Lauritsen, Nicole Cross, Alan K. Davis, Harold Rosenberg, Francis Bonadio & Brent Lang. (2015) Self-Medication of Somatic and Psychiatric Conditions Using Botanical Marijuana. Journal of Psychoactive Drugs 47:5, pages 345-350.
Read now
Read now
Jane A. Fischer, Alexandra M. Clavarino, Maria Plotnikova & Jackob M. Najman. (2015) Cannabis Use and Quality of Life of Adolescents and Young Adults: Findings from an Australian Birth Cohort. Journal of Psychoactive Drugs 47:2, pages 107-116.
Read now
Read now
Nickolas Zaller, Ariel Topletz, Susan Frater, Gail Yates & Michelle Lally. (2015) Profiles of Medicinal Cannabis Patients Attending Compassion Centers in Rhode Island. Journal of Psychoactive Drugs 47:1, pages 18-23.
Read now
Read now
Elon Eisenberg, Miri Ogintz & Shlomo Almog. (2014) The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered-Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study. Journal of Pain & Palliative Care Pharmacotherapy 28:3, pages 216-225.
Read now
Read now
Stephen M. Stout & Nina M. Cimino. (2014) Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metabolism Reviews 46:1, pages 86-95.
Read now
Read now
Articles from other publishers (145)
Maryem El Oihabi, Mohammed Soultana, Mohammed Ammari, Laïla Ben Allal & Asmaa Fakih Lanjri. (2024) Diversity and variability of bioactive compounds in Cannabis sativa: Effects on therapeutic and environmental uses and orientations for future research. Case Studies in Chemical and Environmental Engineering 9, pages 100732.
Crossref
Crossref
Kirsten R. Müller-Vahl. (2024) Cannabinoids in the Treatment of Selected Mental Illnesses: Practical
Approach and Overview of the Literature. Pharmacopsychiatry 57:03, pages 104-114.
Crossref
Crossref
Mark D. Kelley, Marwah Obaid, Edward M. Miller, Marla Bowie & Zachary S. Heeter. (2024) Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients. Medical Cannabis and Cannabinoids 7:1, pages 44-50.
Crossref
Crossref
Tatjana Denneler, Moritz Mahling, Sabine Hermann, Andreas Stengel, Stephan Zipfel, Anne Herrmann-Werner & Teresa Festl-Wietek. (2024) Medical students’ attitudes and perceived competence regarding medical cannabis and its suggestibility. BMC Medical Education 24:1.
Crossref
Crossref
Adam Li, Simon Erridge, Carl Holvey, Ross Coomber, Daniela Barros, Urmila Bhoskar, Matthieu Crews, Lorna Donnelly, Muhammad Imran, Laura Korb, Gracia Mwimba, Simmi Sachdeva-Mohan, James J. Rucker & Mikael H. Sodergren. (2024) UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients. International Clinical Psychopharmacology.
Crossref
Crossref
Haiquan Yang, Kunjie Zhang, Wei Shen, Yuanyuan Xia, Yiting Li & Xianzhong Chen. (2023)
Boosting production of cembratriene‐ol in
Saccharomyces cerevisiae
via systematic optimization
. Biotechnology Journal 19:1.
Crossref
Crossref
AVIJIT MAZUMDER, NAVEEN KUMAR & SAUMYA DAS. (2023) A Comprehensive Review of Gastroesophageal Reflux Disease (GERD) Treatment and its Clinical Perspectives. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) 16:6, pages 7093-7103.
Crossref
Crossref
Adam M. GilmoreMostafa A. ElhendawyMohamed M. RadwanLinda H. Kidder, Amira S. WanasMurrell GodfreyJana B. HildrethA. Edward RobinsonMahmoud A. ElSohly. (2023)
Absorbance-Transmittance Excitation Emission Matrix Method for Quantification of Major Cannabinoids and Corresponding Acids: A Rapid Alternative to Chromatography for Rapid Chemotype Discrimination of
Cannabis sativa
Varieties
. Cannabis and Cannabinoid Research 8:5, pages 911-922.
Crossref
Crossref
Caitlin Wei-Ming Watson, Erin Sundermann, Jonathan Helm, Emily W. Paolillo, Suzi Hong, Ronald J. Ellis, Scott Letendre, Thomas D. Marcotte, Robert K. Heaton, Erin E. Morgan & Igor Grant. (2023) A longitudinal study of cannabis use and risk for cognitive and functional decline among older adults with HIV. AIDS and Behavior 27:10, pages 3401-3413.
Crossref
Crossref
Irene Cheah, Ingrid Gelissen, Jennifer Hunter & Joanna Harnett. (2023) Adverse events associated with the use of cannabis-based products in people living with cancer: A scoping review protocol. European Journal of Integrative Medicine 62, pages 102279.
Crossref
Crossref
Mary K. Piscura, Angela N. Henderson-Redmond, Robert C. Barnes, Swarup Mitra, Josée Guindon & Daniel J. Morgan. (2023) Mechanisms of cannabinoid tolerance. Biochemical Pharmacology 214, pages 115665.
Crossref
Crossref
Graziella Filippini, Silvia Minozzi, Francesca Borrelli, Michela Cinquini & Kerry Dwan. (2023) Cannabinoids in Symptomatic Treatment for People with Multiple Sclerosis: a Systematic Review of Randomised Studies. Current Physical Medicine and Rehabilitation Reports 11:3, pages 303-312.
Crossref
Crossref
Sharon R. Sznitman, Tamar ShochatLukas van RijswijkTalya GreeneJanna Cousijn. (2023) Cannabis and Alcohol Use and Their Associations with Sleep: A Daily Diary Investigation of Single-Use and Co-Use in College Students. Cannabis and Cannabinoid Research 8:3, pages 527-536.
Crossref
Crossref
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, Donald A. P. Brugman, Ulrike F. van Ark, Arwin S. Ramcharan, Paul W. Lebbink, Frederik J. H. Hoogwater, Daan G. Knapen, Derk Jan A. de Groot & Maarten W. Nijkamp. (2023) Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment. Cancers 15:7, pages 2119.
Crossref
Crossref
Fresia Melina Silva Sofrás & Martin Federico Desimone. (2023) Entourage Effect and Analytical Chemistry: Chromatography as a Tool in the Analysis
of the Secondary Metabolism of Cannabis sativa L.. Current Pharmaceutical Design 29:6, pages 394-406.
Crossref
Crossref
Brenden Tervo-Clemmens, William Schmitt, Grace Wheeler, Megan E. Cooke, Randi M. Schuster, Sarah Hickey, Gladys N. Pachas, A. Eden Evins & Jodi M. Gilman. (2023) Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns. Drug and Alcohol Dependence 243, pages 109760.
Crossref
Crossref
Nathália Freitas Freire, Paulo Emílio Feuser, Elena Maria Tovar Ambel, Marco Cordani, Ellen De Pieri, Ricardo Andrez Machado-de-Ávila, Acácio A.F. Zielinski, Claudia Sayer, Pedro Henrique Hermes de Araújo, Guillermo Velasco Díez, Elaine Cabral Albuquerque & Rosana Lopes Lima Fialho. (2023) Preparation and characterization of full-spectrum cannabis extract loaded poly(thioether-ester) nanoparticles: In vitro evaluation of their antitumoral efficacy. Colloids and Surfaces A: Physicochemical and Engineering Aspects 658, pages 130676.
Crossref
Crossref
Haiquan Yang, Kunjie Zhang, Wei Shen, Lei Chen, Yuanyuan Xia, Wei Zou, Yu Cao & Xianzhong Chen. (2023) Efficient production of cembratriene-ol in Escherichia coli via systematic optimization. Microbial Cell Factories 22:1.
Crossref
Crossref
Ivana Ilić-SavićS.S. & Snežana BabacS.S.. (2023) Voice disorders occurred as a result of the use of psychoactive substances. Bastina:60, pages 539-548.
Crossref
Crossref
Divya Vimal, Leonard Clinton D’Souza, Vipin Rai, Samridhi Lal, Anurag Sharma & Subash Chandra Gupta. (2023) Efficacy of Cannabis and its Constituents in Disease Management:
Insights from Clinical Studies. Current Medicinal Chemistry 30:2, pages 178-202.
Crossref
Crossref
Whitney L. Ogle, Gregg J. Gold, Lukas E. Coppen & Claire Copriviza. (2022) How and why adults use cannabis during physical activity. Journal of Cannabis Research 4:1.
Crossref
Crossref
Mary Kathryn Dahlgren, Atilla GonencKelly A. Sagar, Rosemary T. SmithAshley M. LambrosCeline El-AbboudStaci A. Gruber. (2022) Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment. Cannabis and Cannabinoid Research 7:6, pages 827-839.
Crossref
Crossref
Marjan Doppen, Stacey Kung, Ingrid Maijers, Mary John, Harriette Dunphy, Hermaleigh Townsley, Allie Eathorne, Alex Semprini & Irene Braithwaite. (2022) Cannabis in Palliative Care: A Systematic Review of Current Evidence. Journal of Pain and Symptom Management 64:5, pages e260-e284.
Crossref
Crossref
Joshua Aviram, Daniella Atzmony, Anna Frenklakh, Asaf Kroll, Ilana Zaks & Arno Hazekamp. (2022) THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial. Journal of Cannabis Research 4:1.
Crossref
Crossref
Ethan B. Russo, Carrie Cuttler, Ziva D. Cooper, Amanda StueberVenetia L. WhiteleyMichelle Sexton. (2022) Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis and Cannabinoid Research 7:5, pages 706-716.
Crossref
Crossref
Granit Mavraj, Bailey Balouch, Ghiath Alnouri & Robert T. Sataloff. (2022) Alternative and Complimentary Medication Use in Singers: A Pilot Survey. Journal of Voice.
Crossref
Crossref
Maya Lavie-Ajayi. (2022) The Social Construction of Cannabis in Social Work. Social Work 67:4, pages 331-340.
Crossref
Crossref
Dominic S. Carreira, Steven Garden, Allison Huffman & Thomas Ueland. (2022) Cannabinoids in the Orthopedic Setting: A Literature Review. Orthopedics 45:4.
Crossref
Crossref
Faraz Sachedina, Carole Chan, Rahim S. Damji & Olga J. de Sanctis. (2022) Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study. Psychiatry Research 313, pages 114573.
Crossref
Crossref
Que Sabmeethavorn, Yvonne Ann Bonomo & Christine Mary Hallinan. (2022) Pharmacists’ perceptions and experiences of medicinal cannabis dispensing: A narrative review with a systematic approach. International Journal of Pharmacy Practice 30:3, pages 204-214.
Crossref
Crossref
WJ Maule. (2022) The therapeutic use of cannabis in South Africa: panacea or scourge?. The Journal of Medical Laboratory Science and Technology of South Africa 4:2, pages 99-107.
Crossref
Crossref
Sinikka L. Kvamme. (2022) With Medicine in Mind? Exploring the Relevance of Having Recreational Experience When Becoming a Medicinal Cannabis User. Contemporary Drug Problems 49:2, pages 192-212.
Crossref
Crossref
Sarana Rose Sommano, Piyachat Sunanta, Noppol Leksawasdi, Kittisak Jantanasakulwong, Pornchai Rachtanapun, Phisit Seesuriyachan, Yuthana Phimolsiripol, Korawan Sringarm, Warintorn Ruksiriwanich, Pensak Jantrawut & Chuda Chittasupho. (2022) Mass Spectrometry-Based Metabolomics of Phytocannabinoids from Non-Cannabis Plant Origins. Molecules 27:10, pages 3301.
Crossref
Crossref
Régis Vaillancourt, Shannon Gallagher, Jameason D. Cameron & Rahim Dhalla. (2022) Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 155:3, pages 175-180.
Crossref
Crossref
Shiri Procaccia, Gil Moshe Lewitus, Carni Lipson Feder, Anna Shapira, Paula Berman & David Meiri. (2022) Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug. Frontiers in Pharmacology 13.
Crossref
Crossref
Lihi Bar-Lev Schleider, Raphael Mechoulam, Inbal Sikorin, Timna Naftali & Victor Novack. (2022) Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study. Frontiers in Medicine 9.
Crossref
Crossref
Shankar Tumati, Krista L. Lanctôt, RuoDing Wang, Abby Li, Andrew Davis & Nathan Herrmann. (2021) Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects. Drugs & Aging 39:2, pages 153-163.
Crossref
Crossref
Deepak Sharma, Sakshi Bhushan, Dinesh Chandra Agrawal, Manoj K. Dhar & Sanjana Kaul. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare
77
99
.
Renée Martin-Willett, Ashley Master, L. Cinnamon Bidwell & Sharon R. Sznitman. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1369
1398
.
Renée Martin-Willett, Ashley Master, L. Cinnamon Bidwell & Sharon R. Sznitman. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
30
.
Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Mark Ware, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye & Clermont E. Dionne. (2021) Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. Journal of Cannabis Research 3:1.
Crossref
Crossref
Philippe Lucas, Susan Boyd, M.-J. Milloy & Zach Walsh. (2021) The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients. Journal of Cannabis Research 3:1.
Crossref
Crossref
Jennifer H Walsh, Kathleen J Maddison, Tim Rankin, Kevin Murray, Nigel McArdle, Melissa J Ree, David R Hillman & Peter R Eastwood. (2021) Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. SLEEP 44:11.
Crossref
Crossref
Benedikte Kudahl, Marie Eva Berg, Christine Merrild Posselt, Merete Nordentoft & Carsten Hjorthøj. (2021) Medical cannabis and cannabis-based medicine show both potential efficacy and potential harms: Cross-sectional comparison with controls on self-rated and interviewer-rated outcomes within the Danish pilot program on medical cannabis. Complementary Therapies in Clinical Practice 45, pages 101476.
Crossref
Crossref
Benthe H. Doeve, Maartje M. van de Meeberg, Fiona D.M. van Schaik & Herma H. Fidder. (2021) A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 55:9, pages 798-809.
Crossref
Crossref
Tarang Parekh & Farhan Fahim. (2021) Building risk prediction models for daily use of marijuana using machine learning techniques. Drug and Alcohol Dependence 225, pages 108789.
Crossref
Crossref
Salar Vaseghi, Shirin Arjmandi-Rad, Mohammad Nasehi & Mohammad-Reza Zarrindast. (2021) Cannabinoids and sleep-wake cycle: The potential role of serotonin. Behavioural Brain Research 412, pages 113440.
Crossref
Crossref
Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup. (2021) Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduction Journal 18:1.
Crossref
Crossref
Atefeh Noori, Anna Miroshnychenko, Yaadwinder Shergill, Vahid Ashoorion, Yasir Rehman, Rachel J Couban, D Norman Buckley, Lehana Thabane, Mohit Bhandari, Gordon H Guyatt, Thomas Agoritsas & Jason W Busse. (2021) Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ Open 11:7, pages e047717.
Crossref
Crossref
Shaina P. Cahill, Stephanie E. Lunn, Patrick Diaz & Jonathan E. Page. (2021) Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada. Frontiers in Public Health 9.
Crossref
Crossref
Howard Meng, M. Gabrielle Page, Prabjit Ajrawat, Amol Deshpande, Bana Samman, Mary Dominicis, Karim S. Ladha, Joseph Fiorellino, Alexander Huang, Yuvaraj Kotteeswaran, Alex McClaren-Blades, Lakshmi P. Kotra & Hance Clarke. (2021) Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patientsRésultats rapportés par les patients consommant du cannabis médical : une étude observationnelle longitudinale prospective chez des patients souffrant de douleur chronique. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 68:5, pages 633-644.
Crossref
Crossref
Shah Khalid, Faisal A. Almalki, Taibi Ben Hadda, Ammar Bader, Tareq Abu-Izneid, Malika Berredjem, Eman R. Elsharkawy & Ali M. Alqahtani. (2021) Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?. Current Pharmaceutical Design 27:13, pages 1564-1578.
Crossref
Crossref
Franjo GrotenhermenKirsten R. Müller-Vahl. (2021) Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids. Cannabis and Cannabinoid Research 6:2, pages 82-87.
Crossref
Crossref
Ran Abuhasira, Yosef S. Haviv, Merav Leiba, Adi Leiba, Larisa Ryvo & Victor Novack. (2021) Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study. European Journal of Internal Medicine 86, pages 79-85.
Crossref
Crossref
Martyna Hordowicz, Anna Klimkiewicz, Jerzy Jarosz, Maria Wysocka & Monika Jastrzębska. (2021) Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review. Drug and Alcohol Dependence 221, pages 108652.
Crossref
Crossref
Latha Velayudhan, Katie McGoohan & Sagnik Bhattacharyya. (2021) Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLOS Medicine 18:3, pages e1003524.
Crossref
Crossref
Jiries Meehan-Atrash, Wentai Luo, Kevin J. McWhirter, David G. Dennis, David Sarlah, Robert P. Jensen, Isaac Afreh, Jia Jiang, Kelley C. Barsanti, Alisha Ortiz & Robert M. Strongin. (2021) The influence of terpenes on the release of volatile organic compounds and active ingredients to cannabis vaping aerosols. RSC Advances 11:19, pages 11714-11723.
Crossref
Crossref
Philippe Lucas, Susan Boyd, M.-J. Milloy & Zach Walsh. (2021) Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study. Pain Medicine 22:3, pages 727-739.
Crossref
Crossref
Sharon R. Sznitman, Simon Vulfsons, David Meiri & Galit Weinstein. (2020) Medical cannabis and cognitive performance in middle to old adults treated for chronic pain. Drug and Alcohol Review 40:2, pages 272-280.
Crossref
Crossref
Mahmoud Abu-Amna, Talal Salti, Mona Khoury, Idan Cohen & Gil Bar-Sela. (2021) Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?. Current Treatment Options in Oncology 22:2.
Crossref
Crossref
Issbella Bowles. (2021) Thc-You Later Chronic Pain?. Psych-Talk 1:98, pages 13-18.
Crossref
Crossref
Samridhi Lal, Anusmita Shekher, Puneet, Acharan S. Narula, Heidi Abrahamse & Subash C. Gupta. (2021) Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities. Pharmacological Research 163, pages 105302.
Crossref
Crossref
Meagan Jozwiak, Meghan Caballero & Hong Wu. 2021. Complex Regional Pain Syndrome. Complex Regional Pain Syndrome
273
310
.
Philippe Lucas, Susan Boyd, M-J Milloy & Zach Walsh. (2020) Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada. International Journal of Drug Policy 86, pages 102963.
Crossref
Crossref
Stanley Sau Ching Wong, Wing Shing Chan & Chi Wai Cheung. (2020) Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression. Journal of Neuroimmune Pharmacology 15:4, pages 801-829.
Crossref
Crossref
Paola Perin, Alex Mabou Tagne, Paolo Enrico, Franca Marino, Marco Cosentino, Roberto Pizzala & Cinzia Boselli. (2020) Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective. Frontiers in Neurology 11.
Crossref
Crossref
Anastasia S. Suraev, Nathaniel S. Marshall, Ryan Vandrey, Danielle McCartney, Melissa J. Benson, Iain S. McGregor, Ronald R. Grunstein & Camilla M. Hoyos. (2020) Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies. Sleep Medicine Reviews 53, pages 101339.
Crossref
Crossref
Dvora Izgelov, Elyad Davidson, Dinorah Barasch, Aviva Regev, Abraham J. Domb & Amnon Hoffman. (2020) Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers. European Journal of Pharmaceutics and Biopharmaceutics 154, pages 108-115.
Crossref
Crossref
Dvora Izgelov, Michael Freidman & Amnon Hoffman. (2020) Investigation of cannabidiol gastro retentive tablets based on regional absorption of cannabinoids in rats. European Journal of Pharmaceutics and Biopharmaceutics 152, pages 229-235.
Crossref
Crossref
José C. Bouso, Daniel Jiménez‐Garrido, Genís Ona, Damian Woźnica, Rafael G. dos Santos, Jaime E.C. Hallak, Beatriz A. P. B. Paranhos, Felipe de Almeida Mendes, Mauricio Yonamine, Miguel Á. Alcázar‐Córcoles & Magí Farré. (2020) Quality of Life, Mental Health, Personality and Patterns of Use in Self‐Medicated Cannabis Users with Chronic Diseases: A 12‐Month Longitudinal Study. Phytotherapy Research 34:7, pages 1670-1677.
Crossref
Crossref
Dvora Izgelov, Aviva Regev, Abraham J. Domb & Amnon Hoffman. (2020) Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats. Molecular Pharmaceutics 17:6, pages 1979-1986.
Crossref
Crossref
Almog Uziel, Anat Gelfand, Keren Amsalem, Paula Berman, Gil M. Lewitus, David Meiri & Dan Y. Lewitus. (2020)
Full-Spectrum
Cannabis
Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect
. ACS Applied Materials & Interfaces 12:21, pages 23707-23716.
Crossref
Crossref
Daniel J. Kruger, Jessica S. Kruger & R. Lorraine Collins. (2020) Cannabis Enthusiasts’ Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use. American Journal of Health Promotion 34:4, pages 436-439.
Crossref
Crossref
Galit Weinstein & Sharon R. Sznitman. (2020) The implications of late-life cannabis use on brain health: A mapping review and implications for future research. Ageing Research Reviews 59, pages 101041.
Crossref
Crossref
Sharon R. Sznitman, Tamar Shochat & Talya Greene. (2020) Is time elapsed between cannabis use and sleep start time associated with sleep continuity? An experience sampling method. Drug and Alcohol Dependence 208, pages 107846.
Crossref
Crossref
Roy Upton. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
470
483.e5
.
Leonie M. MilosevNikolas PsathakisNatalia SzejkoEwgeni JakubovskiKirsten R. Müller-Vahl. (2019) Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey. Cannabis and Cannabinoid Research 4:4, pages 265-274.
Crossref
Crossref
Ran Abuhasira, Addie Ron, Inbal Sikorin & Victor Novack. (2019) Medical Cannabis for Older Patients—Treatment Protocol and Initial Results. Journal of Clinical Medicine 8:11, pages 1819.
Crossref
Crossref
Òscar Parés-Franquero, Xavier Jubert-Cortiella, Sergi Olivares-Gálvez, Albert Díaz-Castellano, Daniel F. Jiménez-Garrido & José Carlos Bouso. (2019) Use and Habits of the Protagonists of the Story: Cannabis Social Clubs in Barcelona. Journal of Drug Issues 49:4, pages 607-624.
Crossref
Crossref
Jehad Ahmad Barakji, Steven Kwasi Korang, Joshua Feinberg, Mathias Maagard, Christian Gluud, Ole Mathiesen & Janus Christian Jakobsen. (2019) Cannabinoids versus placebo or no intervention for pain: protocol for a systematic review with meta-analysis and trial sequential analysis. BMJ Open 9:10, pages e031574.
Crossref
Crossref
Jiries Meehan-Atrash, Wentai Luo, Kevin J. McWhirter & Robert M. Strongin. (2019) Aerosol Gas-Phase Components from Cannabis E-Cigarettes and Dabbing: Mechanistic Insight and Quantitative Risk Analysis. ACS Omega 4:14, pages 16111-16120.
Crossref
Crossref
Randi von Wrede, Susanna Moskau-Hartmann, Nicola Amarell, Christian Erich Elger & Christoph Helmstaedter. (2019) Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center. Epilepsy & Behavior 99, pages 106458.
Crossref
Crossref
Kathleen A. Russell. (2019) Caring for Patients Using Medical Marijuana. Journal of Nursing Regulation 10:3, pages 47-61.
Crossref
Crossref
Thomas R. Arkell, Richard C. Kevin, Jordyn Stuart, Nicholas Lintzeris, Paul S. Haber, Johannes G. Ramaekers & Iain S. McGregor. (2019)
Detection of Δ
9
THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices
. Drug Testing and Analysis 11:10, pages 1486-1497.
Crossref
Crossref
Jiries Meehan-Atrash, Tetiana Korzun & Aaron Ziegler. (2019) Cannabis Inhalation and Voice Disorders. JAMA Otolaryngology–Head & Neck Surgery 145:10, pages 956.
Crossref
Crossref
Kent E. HutchisonSarah L. HagertyJeffrey GalinkinAngela D. BryanL. Cinnamon Bidwell. (2019) Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data. Cannabis and Cannabinoid Research 4:3, pages 158-164.
Crossref
Crossref
Danielle Brown, Michael Watson & Janet Schloss. (2019) Pharmacological evidence of medicinal cannabis in oncology: a systematic review. Supportive Care in Cancer 27:9, pages 3195-3207.
Crossref
Crossref
Kenneth Brummel-Smith & Freddi Segal-Gidan. (2019) Medical Cannabis Policy: Considerations for Older Patients and Their Health-Care Providers. Public Policy & Aging Report 29:3, pages 106-110.
Crossref
Crossref
Jesse D. Kosiba, Stephen A. Maisto & Joseph W. Ditre. (2019) Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine 233, pages 181-192.
Crossref
Crossref
Dean T. EurichJohn G. HanlonJamie J. BoisvenueHoward MengJason R.B. Dyck. (2019) A Description of the Medical Cannabis Use in Ontario, Canada. Cannabis and Cannabinoid Research 4:2, pages 131-135.
Crossref
Crossref
Henry L. Blanton, Jennifer Brelsfoard, Nathan DeTurk, Kevin Pruitt, Madhusudhanan Narasimhan, Daniel J. Morgan & Josée Guindon. (2019) Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain. Drugs 79:9, pages 969-995.
Crossref
Crossref
Tamara PringsheimMichael S. OkunKirsten Müller-VahlDavide MartinoJoseph JankovicAndrea E. CavannaDouglas W. WoodsMichael RobinsonElizabeth JarvieVeit RoessnerMaryam OskouiYolanda Holler-ManaganJohn Piacentini. (2019) Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92:19, pages 896-906.
Crossref
Crossref
Kyle M. Gardiner, Judith A. Singleton, Janie Sheridan, Gregory J. Kyle & Lisa M. Nissen. (2019) Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – A systematic review. PLOS ONE 14:5, pages e0216556.
Crossref
Crossref
Luigi Romano & Arno Hazekamp. (2019) An Overview of Galenic Preparation Methods for Medicinal Cannabis. Current Bioactive Compounds 15:2, pages 174-195.
Crossref
Crossref
Xiaozhou Luo, Michael A. Reiter, Leo d’Espaux, Jeff Wong, Charles M. Denby, Anna Lechner, Yunfeng Zhang, Adrian T. Grzybowski, Simon Harth, Weiyin Lin, Hyunsu Lee, Changhua Yu, John Shin, Kai Deng, Veronica T. Benites, George Wang, Edward E. K. Baidoo, Yan Chen, Ishaan Dev, Christopher J. Petzold & Jay D. Keasling. (2019) Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature 567:7746, pages 123-126.
Crossref
Crossref
John C. Ashton. (2019) Is Cannabis Harmless? Focus on Brain Function. Current Drug Research Reviews 11:1, pages 33-39.
Crossref
Crossref
Alessandra Bettiol, Niccolò Lombardi, Giada Crescioli, Valentina Maggini, Eugenia Gallo, Alessandro Mugelli, Fabio Firenzuoli, Roberto Baronti & Alfredo Vannacci. (2019) Galenic Preparations of Therapeutic Cannabis sativa Differ in Cannabinoids Concentration: A Quantitative Analysis of Variability and Possible Clinical Implications. Frontiers in Pharmacology 9.
Crossref
Crossref
CHAOWALIT MONTON, FAMEERA MADAKA, SUKANYA SETTHARAKSA, THANIYA WUNNAKUP, JIRAPORNCHAI SUKSAEREE & THANAPAT SONGSAK. (2019) Optimal condition of cannabis maceration to obtain the high cannabidiol and Δ9-tetrahydrocannabinol content. Anais da Academia Brasileira de Ciências 91:3.
Crossref
Crossref
Ian R. Reynolds, Danielle R. Fixen, Bennett L. Parnes, Hillary D. Lum, Prajakta Shanbhag, Skotti Church, Sunny A. Linnebur & Gretchen Orosz. (2018) Characteristics and Patterns of Marijuana Use in Community‐Dwelling Older Adults. Journal of the American Geriatrics Society 66:11, pages 2167-2171.
Crossref
Crossref
Wajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, Silvia Alessi-Severini, Paul Daeninck, James Bolton, Jitender Sareen & Christine Leong. (2018) Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study. CMAJ Open 6:4, pages E637-E642.
Crossref
Crossref
Nicholas Lintzeris, Jessica Driels, Natalie Elias, Jonathon C Arnold, Iain S McGregor & David J Allsop. (2018) Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS‐16). Medical Journal of Australia 209:5, pages 211-216.
Crossref
Crossref
. (2018) Appendix C: References (Part I). Journal of Nursing Regulation 9:2, pages S52-S58.
Crossref
Crossref
. (2018) APRNs Certifying a Medical Marijuana Qualifying Condition. Journal of Nursing Regulation 9:2, pages S39-S45.
Crossref
Crossref
. (2018) Medical Marijuana Education in APRN Nursing Programs. Journal of Nursing Regulation 9:2, pages S33-S38.
Crossref
Crossref
. (2018) Part I: Current Legislation, Scientific Literature Review, and Nursing Implications. Journal of Nursing Regulation 9:2, pages S6-S21.
Crossref
Crossref
Mafalda Pardal & Frédérique Bawin. (2018) The Supply of Cannabis for Medical Use Through Cannabis Social Clubs in Belgium. Contemporary Drug Problems 45:2, pages 127-145.
Crossref
Crossref
Hanan Khalil. (2018) Medicinal cannabis. International Journal of Evidence-Based Healthcare 16:2, pages 81-82.
Crossref
Crossref
Lucas M. Bryant, Kelly E. Daniels, David M. CognettiPatrick Tassone, Adam J. LuginbuhlJoseph M. Curry. (2018) Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients. Laryngoscope Investigative Otolaryngology 3:3, pages 169-177.
Crossref
Crossref
Kim Madden, Niek van der Hoek, Simrun Chona, Annie George, Tristiana Dalchand, Hassan Baldawi, George Mammen & Mohit Bhandari. (2018) Cannabinoids in the Management of Musculoskeletal Pain. JBJS Reviews 6:5, pages e7-e7.
Crossref
Crossref
Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam & Victor Novack. (2018) Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine 49, pages 44-50.
Crossref
Crossref
Frédérique Bawin. (2018) Medisch gebruik van cannabis en zijn psychoactieve werking: een paradox?The medical use of cannabis and its psychoactive activity: a paradox?. Verslaving 14:1, pages 3-15.
Crossref
Crossref
Koby Cohen & Aviv Weinstein. (2018) The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review. Brain Sciences 8:3, pages 40.
Crossref
Crossref
Cayley Russell, Sergio Rueda, Robin Room, Mark Tyndall & Benedikt Fischer. (2018) Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis. International Journal of Drug Policy 52, pages 87-96.
Crossref
Crossref
Marian Wilson, Hannah Y. Gogulski, Carrie Cuttler, Teresa L. Bigand, Oladunni Oluwoye, Celestina Barbosa-Leiker & MaryLee A. Roberts. (2018) Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder. Addictive Behaviors 77, pages 225-231.
Crossref
Crossref
Shawnta L. Lloyd & Catherine W. Striley. (2018) Marijuana Use Among Adults 50 Years or Older in the 21st Century. Gerontology and Geriatric Medicine 4, pages 233372141878166.
Crossref
Crossref
Kirsten Müller-Vahl. (2018) Cannabis-basierte Medikamente: therapeutisches Potenzial und praktische Anwendung. PSYCH up2date 12:01, pages 19-33.
Crossref
Crossref
Halil Kara. (2017) Abuse of Cannabinoids. Ankara Medical Journal.
Crossref
Crossref
Philippe Lucas. (2017) Rationale for cannabis-based interventions in the opioid overdose crisis. Harm Reduction Journal 14:1.
Crossref
Crossref
Yih-Ing Hser, Larissa J. Mooney, David Huang, Yuhui Zhu, Rachel L. Tomko, Erin McClure, Chih-Ping Chou & Kevin M. Gray. (2017) Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment 81, pages 53-58.
Crossref
Crossref
Namkee G. Choi, Diana M. DiNitto & C. Nathan Marti. (2017) Older adults who use or have used marijuana: Help-seeking for marijuana and other substance use problems. Journal of Substance Abuse Treatment 77, pages 185-192.
Crossref
Crossref
Paris Charilaou, Kanishk Agnihotri, Pablo Garcia, Apurva Badheka, Douglas Frenia & Balaji Yegneswaran. (2017) Trends of Cannabis Use Disorder in the Inpatient: 2002 to 2011. The American Journal of Medicine 130:6, pages 678-687.e7.
Crossref
Crossref
Simon Jones, Roy Porter & Chris Bishop. (2017) The implementation of medical ganja in Jamaica. International Journal of Drug Policy 42, pages 115-117.
Crossref
Crossref
Philippe Lucas & Zach Walsh. (2017) Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy 42, pages 30-35.
Crossref
Crossref
Benjamin H. Han, Scott Sherman, Pia M. Mauro, Silvia S. Martins, James Rotenberg & Joseph J. Palamar. (2017) Demographic trends among older cannabis users in the United States, 2006-13. Addiction 112:3, pages 516-525.
Crossref
Crossref
A.S. Kanaan & K.R. Müller-Vahl. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
883
892
.
Samantha Shiplo, Mark Asbridge, Scott T. Leatherdale & David Hammond. (2016) Medical cannabis use in Canada: vapourization and modes of delivery. Harm Reduction Journal 13:1.
Crossref
Crossref
Michelle SextonCarrie CuttlerJohn S. FinnellLaurie K. Mischley. (2016) A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy. Cannabis and Cannabinoid Research 1:1, pages 131-138.
Crossref
Crossref
Ernest Small. 2016. Cannabis. Cannabis
229
252
.
Cinzia Citti, Giuseppe Ciccarella, Daniela Braghiroli, Carlo Parenti, Maria Angela Vandelli & Giuseppe Cannazza. (2016) Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. Journal of Pharmaceutical and Biomedical Analysis 128, pages 201-209.
Crossref
Crossref
Erin M. Rock, Cassidy Connolly, Cheryl L. Limebeer & Linda A. Parker. (2016) Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models. Psychopharmacology 233:18, pages 3353-3360.
Crossref
Crossref
Rosalie Liccardo Pacula, Mireille Jacobson & Ervant J. Maksabedian. (2016) In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction 111:6, pages 973-980.
Crossref
Crossref
Arno Hazekamp. (2016) Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis. Frontiers in Pharmacology 7.
Crossref
Crossref
Claudia Drossel, Martin Forchheimer & Michelle A. Meade. (2016) Characteristics of Individuals with Spinal Cord Injury Who Use Cannabis for Therapeutic Purposes. Topics in Spinal Cord Injury Rehabilitation 22:1, pages 3-12.
Crossref
Crossref
Alexis Kuerbis, Rachel Chernick & Daniel S. Gardner. 2016. Alcohol and Aging. Alcohol and Aging
35
53
.
Benedikt Fischer, Cayley Russell & Mark W. Tyndall. (2015) Cannabis vaping and public health—some comments on relevance and implications. Addiction 110:11, pages 1705-1706.
Crossref
Crossref
Richard Glickman-Simon & Tammy Lindsay. (2015) Cannabinoids for Chronic Pain, Mediterranean Diet and Cognitive Function; Vitamin E and Selenium for Cataract Prevention; Acupuncture and Moxibustion for Primary Dysmenorrhea; Massage Therapy and In Vitro Fertilization. EXPLORE 11:6, pages 489-493.
Crossref
Crossref
Muhammad Saqib Isahq, Muhammad Siddique Afridi, Javid Ali, Muhammad Medrar Hussain, Sohail Ahmad & Farina Kanwal. (2015) Proximate composition, phytochemical screening, GC-MS studies of biologically active cannabinoids and antimicrobial activities of Cannabis indica. Asian Pacific Journal of Tropical Disease 5:11, pages 897-902.
Crossref
Crossref
AIA Ahmed, MA van der Marck, GAH van den Elsen & MGM Olde Rikkert. (2015) Cannabinoids in late‐onset Alzheimer's disease. Clinical Pharmacology & Therapeutics 97:6, pages 597-606.
Crossref
Crossref
Ruth Gallily, Zhannah Yekhtin & Lumír Ondřej Hanuš. (2015) Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using <i>Cannabis</i> Extract Enriched in Cannabidiol. Pharmacology & Pharmacy 06:02, pages 75-85.
Crossref
Crossref
Jean-Francois Etter. (2015) Electronic Cigarettes and Cannabis: An Exploratory Study. European Addiction Research 21:3, pages 124-130.
Crossref
Crossref
Kirsten R. Müller-Vahl. 2015. Cannabinoids in Neurologic and Mental Disease. Cannabinoids in Neurologic and Mental Disease
227
245
.
Amir I.A. Ahmed, Geke A.H. van den Elsen, Angela Colbers, Marjolein A. van der Marck, David M. Burger, Ton B. Feuth, Marcel G.M. Olde Rikkert & Cornelis Kramers. (2014) Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial. European Neuropsychopharmacology 24:9, pages 1475-1482.
Crossref
Crossref
G.A.H. van den Elsen, A.I.A. Ahmed, M. Lammers, C. Kramers, R.J. Verkes, M.A. van der Marck & M.G.M. Olde Rikkert. (2014) Efficacy and safety of medical cannabinoids in older subjects: A systematic review. Ageing Research Reviews 14, pages 56-64.
Crossref
Crossref
Amir I. A. Ahmed, Geke A. H. van den Elsen, Marjolein A. van der Marck & Marcel G. M. Olde Rikkert. (2014) Medicinal Use of Cannabis and Cannabinoids in Older Adults: Where Is the Evidence?. Journal of the American Geriatrics Society 62:2, pages 410-411.
Crossref
Crossref
Zach Walsh, Robert Callaway, Lynne Belle-Isle, Rielle Capler, Robert Kay, Philippe Lucas & Susan Holtzman. (2013) Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. International Journal of Drug Policy 24:6, pages 511-516.
Crossref
Crossref